Hutch News
Results per Page:
New Science Spotlight Articles
Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
May 16, 2022
Access to Prostate Cancer Clinical Trials: A County-Level Analysis
From the Bansal Group, Public Health Sciences Division
Latest Fred Hutch research on COVID-19
How Hutch scientists have been tackling coronavirus in lab and clinic
IAVI and Moderna launch trial of HIV vaccine antigens delivered through mRNA technology
Phase 1 trial aims to build on response seen in proof-of-concept trial
Increasing BIPOC inclusion in clinical trials
From the COVID-19 Prevention Network, Vaccine and Infectious Disease Division
Cancer clinical trials exclude too many patients: That’s changing
Calls for equity, inclusion and better access boost pre-pandemic efforts to open up eligibility, streamline trials
Tip Sheet: Disparities in cancer outcomes, catching up on cancer screenings, boosting immunotherapy effectiveness and SARS-CoV-2 origins
Summaries of recent Fred Hutch research findings and other news
The COVID-19 pandemic and new clinical trial activations
From the The Unger Group, Division of Public Health Sciences
Tip Sheet: Diversity in vaccine clinical trials, behind-the-scenes look at COVID-19 biostats, new cell therapy approved, plus meet ‘Megasphaera hutchinsoni’
Summaries of recent Fred Hutch research findings and other news
Women’s Health Initiative continues on at Fred Hutch
Nearly 30 years after its launch, the WHI and its data are still going strong, producing key findings
New study highlights lack of diversity and inclusion in vaccine clinical trials
Analysis shows certain racial/ethnic groups and older people aren’t being adequately represented and trial reporting guidelines aren’t being followed
Tip Sheet: Celebrate holidays safely, COVID-19 vaccines, challenges in HIV vaccine trials — and new insights on evolution
Summaries of recent Fred Hutch research findings and other news, plus resources for the American Society of Hematology’s annual meeting
Cancer clinical trials: Creativity in the face of COVID-19
Faced with a global pandemic, scientists prioritize safety, patient benefit
Experts discuss navigating cancer and cancer research during the pandemic
Hutch panelists offer their insights on how COVID-19 has impacted patients as well as their efforts to develop cancer treatments
Fred Hutch opens COVID-19 Clinical Research Center
Newly renovated facility is among the first stand-alone centers specifically designed to test novel interventions such as monoclonal antibodies and antivirals to treat and prevent COVID-19
Survival of cancer patients who did not meet standard trial eligibility
From the Percival Group, Public Health Sciences Division
Making clinical trial information more accessible
Dr. Heather Cheng wins NCI award to develop new ways to translate and educate patients and providers
Dr. Martin 'Mac' Cheever, cancer immunotherapy expert, receives distinguished service award
Honor recognizes his work establishing Cancer Immunotherapy Trials Network
High impact of positive and negative clinical trial results
From the Unger Group, Division of Public Health Sciences
Failed Alzheimer’s drug boosts CAR T-cell therapy
Engineered immune cells get a helping hand in new clinical trial for multiple myeloma patients
Cancer patients find clinical trials, hope and help
#NWMetsConf connects metastatic breast cancer patients with trials, treatments, tools and each other